0001214659-21-010654.txt : 20211020
0001214659-21-010654.hdr.sgml : 20211020
20211020175903
ACCESSION NUMBER: 0001214659-21-010654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211019
FILED AS OF DATE: 20211020
DATE AS OF CHANGE: 20211020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Yili Kevin
CENTRAL INDEX KEY: 0001793506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 211335087
MAIL ADDRESS:
STREET 1: C/O VIEWRAY, INC.
STREET 2: 2 THERMO FISHER WAY
CITY: OAKWOOD VILLAGE
STATE: OH
ZIP: 44146
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-54036.xml
PRIMARY DOCUMENT
X0306
4
2021-10-19
0001293310
HUMANIGEN, INC
HGEN
0001793506
Xie Yili Kevin
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
true
false
false
false
Stock Option (Right to Buy)
6.56
2021-10-19
4
A
false
42866
0
A
2022-03-31
2031-10-18
Common Stock
42866
42866
D
The option vests in 12 ratable quarterly installments commencing March 31, 2022.
/s/ Timothy E. Morris, Attorney-in-Fact
2021-10-20